Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10333047rdf:typepubmed:Citationlld:pubmed
pubmed-article:10333047lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0271650lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0017785lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0041485lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C1305855lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C1419119lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0918012lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:10333047lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:10333047pubmed:issue5lld:pubmed
pubmed-article:10333047pubmed:dateCreated1999-7-2lld:pubmed
pubmed-article:10333047pubmed:abstractTextOur aims were to investigate the concentrations and prevalence of autoantibodies against the Mr 65.000 isoform of glutamate decarboxylase (GAD65) and the tyrosine phosphatase-like protein (IA-2) in adults and to test the hypothesis that GAD65 and IA-2 autoantibodies in a regional population are related to abnormal oral glucose tolerance.lld:pubmed
pubmed-article:10333047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:languageenglld:pubmed
pubmed-article:10333047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:citationSubsetIMlld:pubmed
pubmed-article:10333047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10333047pubmed:statusMEDLINElld:pubmed
pubmed-article:10333047pubmed:monthMaylld:pubmed
pubmed-article:10333047pubmed:issn0012-186Xlld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:HallmansGGlld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:NilssonMMlld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:LernmarkAAlld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:HäggEElld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:JanssonGGlld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:HampeCClld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:SullivanE...lld:pubmed
pubmed-article:10333047pubmed:authorpubmed-author:RolandssonOOlld:pubmed
pubmed-article:10333047pubmed:issnTypePrintlld:pubmed
pubmed-article:10333047pubmed:volume42lld:pubmed
pubmed-article:10333047pubmed:ownerNLMlld:pubmed
pubmed-article:10333047pubmed:authorsCompleteYlld:pubmed
pubmed-article:10333047pubmed:pagination555-9lld:pubmed
pubmed-article:10333047pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:meshHeadingpubmed-meshheading:10333047...lld:pubmed
pubmed-article:10333047pubmed:year1999lld:pubmed
pubmed-article:10333047pubmed:articleTitleGlutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index.lld:pubmed
pubmed-article:10333047pubmed:affiliationDepartment of Family Medicine, Umeå University, Sweden.lld:pubmed
pubmed-article:10333047pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10333047pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10333047pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10333047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10333047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10333047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10333047lld:pubmed